Stephen P. Carey - 05 Mar 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP & CFO
Signature
/s/ Stephen P. Carey, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
05 Mar 2026
Net transactions value
-$552,031
Form type
4
Filing time
05 Mar 2026, 17:46:28 UTC
Previous filing
02 Mar 2026
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CAREY STEPHEN P. SVP & CFO C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Stephen P. Carey, by attorney-in-fact Meredith W. Cook 05 Mar 2026 0001674236

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise +3,312 +1.7% $49.51* 192,855 05 Mar 2026 Direct
transaction ANIP Common Stock Sale $249,791 -3,312 -1.7% $75.42 189,543 05 Mar 2026 Direct F1
transaction ANIP Common Stock Sale $302,240 -4,000 -2.1% $75.56 185,543 05 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise -3,312 -25% $49.51* 9,938 05 Mar 2026 Common Stock 3,312 $49.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price.
F2 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.